Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Jabar F, Lombardi P, Torkpour A, Tafavvoghi M, Waaler PNB, Andersen S, Paulsen EE, Pøhl M, Busund LR, Donnem T, Richardsen E, Pinato DJ, Rakaee M(2026) CellPrior-net: Prior-guided nuclei detection and classification for H&E whole-slide images J Pathol Inform, 23, 100716 DOI 10.1016/j.jpi.2026.100716, PubMed 42835573
Schuster C, Oppedal IA, Vinnem LI, Abrahamsson EL, Barrett TM, Steinskog ESS, Giercksky Russnes HE, Helland Å(2026) Targeted ALK inhibition achieving tumour control in metastatic melanoma: a case report Acta Oncol, 65, 814-817 DOI 10.2340/1651-226X.2026.46424, PubMed 42820355
López A, Zobolas J, Dumontier T, Aittokallio T(2026) Multi-modal learning with incomplete data Nat Commun, 17(1) DOI 10.1038/s41467-026-77212-w, PubMed 42811071